Physician

Aqsa Izhar Khan, M.D.

According to 2025 Medicare claims, Aqsa Khan, M.D. (NPI: 1982136883) practices medical oncology, with the plurality of this provider's patient population coming from Gallia, OH. This provider's primary affiliated billing organization is HOLZER CLINIC, LLC (NPI: 1508817248; TIN: 310917085) and primary practice location at 45631-1560. Khan is affiliated with the Pearl Care 4, LLC (ACO ID: A5600), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 72 traditional Medicare patients, billed 141 HCPCS/CPT codes, and received $5,926 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 72 prescription claims across 30 beneficiaries totaling $21,106 in drug costs, led by Anastrozole (Anastrozole). Open Payments data shows 4 records totaling $82. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,212 and ending at $21,106. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.0K$5.9K2024 Medicare payment: $5,926 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202472141$5,926

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$231K$462K2017 Drug cost: $4,212 (USD; Tot_Drug_Cst)2018 Drug cost: $15,111 (USD; Tot_Drug_Cst)2019 Drug cost: $5,494 (USD; Tot_Drug_Cst)2020 Drug cost: $2,131 (USD; Tot_Drug_Cst)2021 Drug cost: $162,895 (USD; Tot_Drug_Cst)2022 Drug cost: $461,893 (USD; Tot_Drug_Cst)2023 Drug cost: $194,961 (USD; Tot_Drug_Cst)2024 Drug cost: $21,106 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171854$4,212
201866216$15,111
201933119$5,494
20202478$2,131
20212957$162,895
202253130$461,893
20233375$194,961
20243072$21,106

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1822$70
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more1414$58
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4658$50
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's3543$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AnastrozoleAnastrozole12840$385
HydroxyureaHydroxyurea12720$329

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$82Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aqsa Izhar Khan, M.D.?

Tedicare shows public-source Medicare data for Aqsa Izhar Khan, M.D. (NPI 1982136883), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aqsa Izhar Khan, M.D. have ACO affiliation data?

Aqsa Izhar Khan, M.D. is shown with ACO affiliation data for Pearl Care 4, LLC (MSSP, ACO ID A5600).

What billing organization is linked to Aqsa Izhar Khan, M.D.?

Aqsa Izhar Khan, M.D. is linked to HOLZER CLINIC, LLC (billing NPI 1508817248) in the available physician profile data.

Does Aqsa Izhar Khan, M.D. have Open Payments data?

Aqsa Izhar Khan, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.